PTGX
NASDAQStockProtagonist Therapeutics, Inc.
$96.17-0.39 (-0.40%)
52-Week Range
$40.89
$97.05
Key Stats
Market Cap
6.1B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.24
Volume
467.9K
Avg Volume
703.2K
Performance
1M
+14.29%
3M
+0.66%
6M
+63.45%
YTD
+9.45%
1Y
+73.81%
3Y
+277.45%
5Y
+209.50%
Price Chart
ETF Exposure
PTGX is held by 130 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| PWS | Pacer WealthShield ETF | 0.22% |
| ISMD | Inspire Small/Mid Cap ETF | 0.21% |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.20% |
| EHLS | Even Herd Long Short ETF | 0.19% |
| IWM | iShares Russell 2000 ETF | 0.19% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.18% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.18% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.18% |
| RSSL | Global X - Russell 2000 ETF | 0.17% |
| JHSC | John Hancock Investments - Multifactor Small Cap ETF | 0.16% |
| VTWO | Vanguard Russell 2000 ETF | 0.15% |
| AFTY | Pacer CSOP FTSE China A50 ETF | 0.15% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.15% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.14% |
| UWM | ProShares - Ultra Russell2000 | 0.13% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.11% |
| AFMC | First Trust Active Factor Mid Cap ETF | 0.11% |
| CLSE | Convergence Long/Short Equity ETF | 0.11% |
| DFAS | Dimensional - US Small Cap ETF | 0.11% |
| URTY | ProShares - UltraPro Russell2000 | 0.11% |
| FSML | Franklin Small Cap Enhanced ETF | 0.11% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.10% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.10% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.09% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.09% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.09% |
| VBK | Vanguard Small-Cap Growth ETF | 0.08% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.07% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.07% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.07% |
| VHT | Vanguard Health Care ETF | 0.06% |
| EZM | WisdomTree U.S. MidCap Fund | 0.06% |
| VXF | Vanguard Extended Market ETF | 0.06% |
| CSF | VictoryShares US Discovery Enhanced Volatility Wtd ETF | 0.05% |
| WSML | iShares MSCI World Small-Cap ETF | 0.05% |
| SMMD | iShares Russell 2500 ETF | 0.04% |
| VB | Vanguard Small-Cap ETF | 0.03% |
| HDG | ProShares - Hedge Replication ETF | 0.03% |
| BDVL | iShares Disciplined Volatility Equity Active ETF | 0.03% |
| MMTM | State Street SPDR S&P 1500 Momentum Tilt ETF | 0.02% |
| RWJ | Invesco S&P SmallCap 600 Revenue ETF | 0.02% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.02% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.01% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.01% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.01% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.01% |
| IWV | iShares Russell 3000 ETF | 0.01% |
| SCHB | Schwab U.S. Broad Market ETF | 0.01% |
| SPTM | State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF | 0.01% |
| VTI | Vanguard Total Stock Market ETF | 0.01% |
About PTGX ETF Exposure
Protagonist Therapeutics, Inc. (PTGX) is held by 130 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 6.1B, PTGX is a widely held institutional stock. The stock currently trades at $96.17. Investors can gain exposure to PTGX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PTGX, sorted by portfolio weight.